Atorvastatin recall 2023

Q: What information can the FDA provide about Ranbaxy s voluntary recall of atorvastatin tablets? A: Ranbaxy initiated this voluntary recall after the company determined there was a quality

2.5 mg/ 40 mg Amlodipine Besylate, Atorvastatin Calcium tablets, 30-count bottles. Manufacturer: Dr. Reddy s Laboratories Limited. Reason: Subpotent drug. 984 bottles recalled. Lot C . Amlodipine Recall, Class III. Recall issued . 5 mg/ 20 mg Amlodipine Besylate, Atorvastatin Calcium tablets, 30-count and 90-count

in all dosage forms over. Atorvastatin Recall 2024 2024 URGENT VOLUNTARY RECALL: UPDATED to Retail/Hospital Level, Initiated

Recall Number: D- : Event ID: : Brand: ATORVASTATIN CALCIUM: Generic Name: ATORVASTATIN CALCIUM: Manufacturer: ATORVASTATIN CALCIUM: Active Substance: ATORVASTATIN CALCIUM TRIHYDRATE: Drug Route: ORAL: Distribution: USA Nationwide: Quantity: a) 375 Bottles b) 323 Bottles: Recall Reason: cGMP Deviations for the manufacturing Firm

recall-losartan-potassium-0recall-announcement. Accessed Atorvastatin 20 mg, pitavastatin 4 mg, and rosuvastatin 10 mg are

Generic atorvastatin recall applies to 90-count bottles of 10

FSIS routinely conducts recall effectiveness checks atorvastatin and lisinopril together to verify recalling firms notify their customers of the tools in

RECALL MARCH-2024 by Nazia Rafique 1. Na Risinolate - Anionic atorvastatin Possible clinical consequence: Statin toxicity with

Drugs Medications; Atorvastatin. Atorvastatin - Uses, Side Effects More on Drugs Medications. Drug Recalls: What Do They Mean